Syntegon acquires Telstar
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
This strategic decision will unlock significant value for our scientific and industrial products business
HaystackAnalytics is engaged in the business of developing genomic analysis software
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Subscribe To Our Newsletter & Stay Updated